JONATHAN D ROOT
CIK 1225480 · last filed 2026-04-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.51B
Companies
9
Total Filings
70
Lifetime Open-Market Net
$9.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OMDA | Director | 180,175 | $17.14 | $3.09M | $0 | 6 | 2026-04-07 |
| CARL | Director | 4,323,139 | $11.42 | $49.37M | $7.00M | 1 | 2025-07-24 |
| EWTX | Director | 15,625 | $34.83 | $544.2K | $250.0K | 6 | 2025-06-18 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $4.81M | 14 | 2025-02-19 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | 10%+ Owner | 129,365 | $0.00 | $78 | -$4.37M | 14 | 2022-08-03 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | 95,588 | $5.87 | $561.1K | $2.04M | 6 | 2022-06-13 |
| GWRE | 10%+ Owner | 11,878,173 | $122.56 | $1.46B | $0 | 1 | 2012-01-30 |
| MXL | 10%+ Owner | 3,378 | $84.46 | $285.3K | -$201.4K | 2 | 2011-05-26 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | Director | — | $10.12 | — | $0 | 3 | 2008-06-13 |
Recent Filings · Page 2 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-31 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2024-04-26 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2023-06-14 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | Inari Medical, Inc. (NARI) Delisted | Exer (M) | +2,982 | $0 | EDGAR |
| 2023-05-19 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +2,412 | $0 | EDGAR |
| 2022-08-03 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Sell (S) | −571,400 | -$456.0K | EDGAR |
| 2022-07-29 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Sell (S) | −162,585 | -$145.0K | EDGAR |
| 2022-07-27 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Sell (S) | −243,595 | -$217.9K | EDGAR |
| 2022-07-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Sell (S) | −101,545 | -$97.6K | EDGAR |
| 2022-07-19 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Sell (S) | −348,205 | -$381.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.